Extracellular matrix protein 1 regulates cell proliferation and trastuzumab resistance through activation of epidermal growth factor signalingopen access
- Authors
- Lee, Kyung-min; Nam, Keesoo; Oh, Sunhwa; Lim, Juyeon; Kim, Young-Pil; Lee, Jong Won; Yu, Jong-Han; Ahn, Sei-Hyun; Kim, Sung-Bae; Noh, Dong-Young; Lee, Taehoon; Shin, Incheol
- Issue Date
- Dec-2014
- Publisher
- BIOMED CENTRAL LTD
- Citation
- BREAST CANCER RESEARCH, v.16, no.6, pp.1 - 17
- Indexed
- SCIE
SCOPUS
- Journal Title
- BREAST CANCER RESEARCH
- Volume
- 16
- Number
- 6
- Start Page
- 1
- End Page
- 17
- URI
- https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/143926
- DOI
- 10.1186/s13058-014-0479-6
- ISSN
- 1465-5411
- Abstract
- Introduction: Extracellular matrix protein 1 (ECM1) is a secreted glycoprotein with putative functions in cell proliferation, angiogenesis and differentiation. Expression of ECM1 in several types of carcinoma suggests that it may promote tumor development. In this study, we investigated the role of ECM1 in oncogenic cell signaling in breast cancer, and potential mechanisms for its effects. Methods: In order to find out the functional role of ECM1, we used the recombinant human ECM1 and viral transduction systems which stably regulated the expression level of ECM1. We examined the effect of ECM1 on cell proliferation and cell signaling in vitro and in vivo. Moreover, tissues and sera of patients with breast cancer were used to confirm the effect of ECM1. Results: ECM1 protein was increased in trastuzumab resistant (TR) cells, in association with trastuzumab resistance and cell proliferation. Through physical interaction with epidermal growth factor receptor (EGFR), ECM1 potentiated the phosphorylation of EGFR and extracellular signal-regulated kinase upon EGF treatment. Moreover, ECM1-induced galectin-3 cleavage through upregulation of matrix metalloproteinase 9 not only improved mucin 1 expression, but also increased EGFR and human epidermal growth factor receptor 3 protein stability as a secondary signaling. Conclusions: ECM1 has important roles in both cancer development and trastuzumab resistance in breast cancer through activation of EGFR signaling.
- Files in This Item
-
- Appears in
Collections - 서울 자연과학대학 > 서울 생명과학과 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/143926)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.